Newsroom

ELEVATE seed grants to help researchers at The Ottawa Hospital improve treatment for inflammatory and immune conditions
February 21, 2024 - The Ottawa Hospital’s Research Institute is awarding four ELEVATE seed grants to help researchers understand the role of inflammation and the immune system in various diseases and develop better treatments.
ELEVATE seed grants to help researchers at The Ottawa Hospital improve prevention and care for kidney disease
February 21, 2024 - The Ottawa Hospital’s Research Institute is awarding five ELEVATE seed grants to kickstart innovative kidney research projects.
MS drug boosts cancer-fighting virus in lab models
February 14, 2024 - “Immune-based therapies for cancer are showing great promise and we hope that research such as this will lead to more benefits for patients,”
Researchers develop “field guide” to 22 ovarian cancer mouse models
February 14, 2024 - Researchers use mouse models of ovarian cancer to better understand the disease and develop new treatments. However, it can be difficult to know which model is best for a particular experiment.
When hormones hurt the heart
February 14, 2024 - “This study shows even mild forms of primary aldosteronism can hurt the heart and blood vessels, even before someone develops high blood pressure.”
See all news items | See only press releases | Search for news and experts by disease / specialty
Media contacts

Amelia Buchanan
Senior Communication Specialist
613-297-8315
ambuchanan@ohri.ca

Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca

Ottawa Hospital Facebook link Ottawa Hospital Twitter link Ottawa Hospital YouTube link Ottawa Hospital LinkedIn link Ottawa Hospital Instagram link